Editas Medicine Inc (GB:0IFK)
LSE:0IFK
Holding GB:0IFK?
Track your performance easily

Editas Medicine (0IFK) Technical Analysis

2 Followers

Technical Sentiment

Overall Consensus
Neutral
8Bullish
6Neutral
8Bearish
Technical Analysis Consensus
Neutral
2Bullish
6Neutral
2Bearish
Moving Average Consensus
Neutral
6Bullish
0Neutral
6Bearish
Editas Medicine Inc’s (0IFK) Moving Averages Convergence Divergence (MACD) indicator is -0.12, suggesting Editas Medicine Inc is a Sell.
Editas Medicine Inc’s (0IFK) 20-Day exponential moving average is 3.36, while Editas Medicine Inc’s (0IFK) share price is $3.38, making it a Buy.
Editas Medicine Inc’s (0IFK) 50-Day exponential moving average is 3.71, while Editas Medicine Inc’s (0IFK) share price is $3.38, making it a Sell.

Editas Medicine (0IFK) Pivot Points

Oct 19, 2024, 09:56 AM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
3.00
3.13
3.20
3.33
3.40
3.53
3.60
Fibonacci
3.13
3.21
3.25
3.33
3.41
3.45
3.53
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Editas Medicine (0IFK) Moving Averages

Oct 19, 2024, 09:56 AM
Period
Simple
Exponential
MA5
3.32Buy
3.31Buy
MA10
3.22Buy
3.29Buy
MA20
3.31Buy
3.36Buy
MA50
3.60Sell
3.71Sell
MA100
4.37Sell
4.38Sell
MA200
5.82Sell
5.79Sell
Editas Medicine Inc’s (0IFK) 10-Day exponential moving average is 3.29, while Editas Medicine Inc’s (0IFK) share price is $3.38, making it a Buy.
Editas Medicine Inc’s (0IFK) 100-Day exponential moving average is 4.38, while Editas Medicine Inc’s (0IFK) share price is $3.38, making it a Sell.
Editas Medicine Inc’s (0IFK) stock price is $3.38 and Editas Medicine Inc’s (0IFK) 50-day simple moving average is 3.60, creating a Sell signal.
Editas Medicine Inc’s (0IFK) stock price is $3.38 and Editas Medicine Inc’s (0IFK) 100-day simple moving average is 4.37, creating a Sell signal.
Editas Medicine Inc’s (0IFK) stock price is $3.38 and Editas Medicine Inc’s (0IFK) 200-day simple moving average is 5.82, creating a Sell signal.

Editas Medicine (0IFK) Technical Indicators

Oct 19, 2024, 09:56 AM
Name
Value
Implied Action
RSI (14)
48.32
Neutral
STOCH (9,6)
69.14
Neutral
STOCHRSI (14)
66.87
Neutral
MACD (12,26)
-0.12
Sell
ADX (14)
23.89
Neutral
Williams %R
-27.14
Buy
CCI (14)
15.01
Neutral
ATR (14)
0.17
-
Ultimate Oscillator
46.56
Neutral
ROC
-2.31
Sell
Editas Medicine Inc’s (0IFK) Relative Strength Index (RSI) is 48.32, creating a Neutral signal.
Editas Medicine Inc’s (0IFK) Trend Strength Indicator (ADX) is 23.89, creating a Neutral signal.
Editas Medicine Inc’s (0IFK) Commodity Channel Index (CCI) is 15.01, creating a Neutral signal.
Editas Medicine Inc’s (0IFK) Price Rate of Change (ROC) is -2.31, creating a Sell signal.

FAQ

Is 0IFK a Buy, Hold, or Sell?
Based on 0IFK’s technical indicators, 0IFK is a Hold.
    What is 0IFK’s RSI (14)?
    0IFK’s RSI (14) is 48.32, which suggests 0IFK is a Neutral.
      What is 0IFK’s MACD?
      0IFK’s MACD is -0.12, which suggests 0IFK is a Sell.
        What is 0IFK’s 5-day moving average?
        0IFK’s 5-day moving average is 3.32, which suggests 0IFK is a Buy.
          What is 0IFK’s 20-day moving average?
          0IFK 20-day moving average is 3.31, which suggests 0IFK is a Buy.
            What is 0IFK’s 50-day moving average?
            0IFK’s 50-day moving average is 3.60, which suggests 0IFK is a Sell.
              What is 0IFK’s 200-day moving average?
              0IFK’s 200-day moving average is 5.82, which suggests 0IFK is a Sell.
                What is 0IFK’s Williams % R (14)?
                0IFK’s Williams % R (14) is -27.14, which suggests 0IFK is a Buy.
                  What is 0IFK’s CCI (14)?
                  0IFK’s CCI (14) is 15.01, which suggests 0IFK is a Neutral.
                    What is the share price of Editas Medicine Inc?
                    What am I Missing?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis